EU Review Proposals ‘Fail To Analyze’ Impact Of Reduced Exclusivity Periods

 
• By Ian Schofield

Plans for the overhaul of the EU’s medicines framework are missing key analysis on the effect of reductions in data and market protection on the pharmaceutical industry, despite an abundance of studies on how such incentives influence company decisions on whether to develop new products, say lawyers from Sidley.

Carrot on a stick motivation illustration.
EU proposals could result in changes to incentives for new drug development • Source: Shutterstock

More from Europe

More from Geography